Table 2.
ID | Frascati score | AAN score | HAND score in the study |
---|---|---|---|
HAND 2 | 3 | 3 | |
HAND 3 | 5 | 5 | |
HAND 4 | 4 | 4 | |
HAND 6 | 4 | 4 | |
HAND 7 | 5 | 5 | |
HAND 11 | 3 | 3 | |
HAND 12 | 2 | 2 | |
HAND 13 | 5 | 5 | |
HAND 14 | 3 | 3 | |
HAND 15 | 3 | 3 | |
HAND 16 | 3 | 3 | |
HAND 17 | 3 | 3 | |
HAND 18 | 2 | 2 | |
HAND 25 | 3 | 3 | |
HAND 26 | 3 | 3 | |
HAND 27 | 3 | 3 | |
HAND 28 | 3 | 3 | |
HAND 29 | 3 | 3 | |
HAND 30 | 3 | 3 | |
HAND 41 | 5 | 4 | 5 |
HAND 44 | 5 | 4 | 5 |
HAND 45 | 3 | 5 | 3 |
AHAND score used in the study was based on the Frascati score where available and the AAN score in other cases. Assuming a correlation between the Frascati and AAN scales [17], the HAND scores correspond to the following clinical classification established for the Frascati criteria: 0, neurocognitively normal, no significant impairment on NP testing; 1, asymptomatic neurocognitive impairment; 2, possible mild neurocognitive disorder; 3, probable mild neurocognitive disorder; 4, possible HIV-associated dementia; 5, probable HIV-associated dementia